author-photo

Mattia Rediti

Université libre de Bruxelles

3

Papers

3

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (3)
Association of T- and B-cell receptor repertoires with molecular subtypes and outcome in HER2+ breast cancer: An analysis of the NeoALTTO clinical trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)